18 December 2025 - Top Stories

Australia’s health sector continues to evolve amid significant developments. Lanas Healthcare has appointed Michael Boyce as a director to bolster its growth in the Australian market, leveraging his extensive experience in healthcare strategy and M&A. This move underscores a broader push by healthtech companies to expand their footprint, particularly through platforms like HealthLink and KonnectNET, which facilitate secure messaging and insurer-practice connectivity.

Meanwhile, the pressure on emergency departments remains high, with patient numbers rising by over 20% in a decade. The government is promoting urgent care services—such as 24/7 nurse advice lines, walk-in clinics, and virtual EDs—to alleviate hospital congestion. Concurrently, Australia’s medical research landscape faces a funding crunch, with only 8% of grant applications successful, risking a slowdown in innovation. The Viertel Foundation’s 30-year milestone highlights ongoing private sector commitment to health research, supporting breakthroughs in cancer and AI-driven healthcare models.

On policy and regulation, reforms are underway to enhance primary care funding, with longer-term arrangements and improved governance proposed for PHNs. The upcoming discontinuation of vial insulin by Eli Lilly and increased funding for psychedelic-assisted therapy reflect shifts in treatment options. Additionally, the rise of AI in healthtech faces data interoperability challenges, which must be addressed to unlock full potential. The sale of HotDoc, a key player in digital health, signals ongoing consolidation and the growing influence of AI and telehealth in healthcare delivery.

• Appointing experienced leaders to accelerate healthtech expansion
• Promoting urgent care to reduce ED pressure
• Addressing funding gaps threatening research innovation
• Reforming primary care funding and governance
• Managing supply changes in insulin and mental health treatments
• Tackling data interoperability issues for AI success
• Monitoring healthtech M&A activity amid market shifts